The novel therapy of the medication represents a major breakthrough in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide789231.blogrelation.com/48670818/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment